Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 20/7/20181 min de lectura
Metered Dose Inhaler and Dry Powder Inhaler Drug Products-Quality Considerations; Draft Guidance for Industry; Reopening of the Comment Period
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA, Agency, or we) is reopening the comment period for the "Metered Dose Inhaler and Dry Powder Inhaler Drug Products--Quality Considerations; Draft Guidance for Industry," published in the Federal Register of April 19, 2018. FDA is reopening the comment period to allow interested persons additional time to submit comments.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →